알레르기 면역치료제 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00008219
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 149
Buy Now

알레르기 면역치료제 시장은 2019년에 미화 18억 1918만 달러로 평가되었으며 2027년에는 미화 41억 8589만 달러에 이를 것으로 예상됩니다. 2020년부터 2027년까지 연평균 성장률(CAGR) 11.1%로 성장할 것으로 예상됩니다.

탈민감화 또는 저민감화라고도 불리는 알레르기 면역요법은 여러 가지에 초점을 맞춘 의학적 치료법입니다. 알레르기의 종류. 알레르기의 유병률이 증가하고 있으며, 약물요법과 같은 기존의 치료 개입은 종종 효과가 없는 것으로 나타났습니다. 결과적으로, 알레르기 면역요법은 면역학적 내성을 증가시키고 질병의 진행 과정을 변화시켜 여러 유형의 알레르기를 치료하는 데 인기가 높아지고 있습니다. 알레르기 면역치료제 시장은 알레르기 질환의 유병률 증가, 설하 투여 제형의 기술 발전과 같은 주요 추진 요인으로 인해 성장할 것으로 예상됩니다. 그러나 알레르기 면역요법의 사용과 관련된 단점 및 지역별 규제 변화로 인해 예측 기간 동안 시장 성장이 저해될 가능성이 높습니다.

알레르기 면역요법의 수익성이 높은 지역 시장


전략적 통찰력

시장 통찰력

알레르기 질환 유병률 증가< /p>

알레르기 장애는 주치의와 소아과 의사가 다루는 가장 일반적인 문제입니다. 선진국 인구의 25% 이상이 알레르기로 고통받고 있습니다. 알레르기는 알레르기 항원에 대한 과잉 면역 반응의 발달로 인해 알레르기 항원에 대한 Th2 극성 사이토카인 반응과 IgE 항체 반응 생성을 특징으로 하는 다양한 장애를 포함합니다.

< p>알레르기 질환의 유병률이 증가함에 따라 알레르기성 천식은 물론 꽃가루, 곰팡이, 동물 등의 알레르겐에 대한 안전하고 효과적인 치료법인 알레르기 면역치료가 필요합니다. 최근 국민 건강 및 영양 조사 조사 보고서에 따르면 인구의 54%가 하나 이상의 알레르기 항원에 대해 양성 반응을 보였습니다. 미국 알레르기 학회(American Academy of Allergy)에 따르면 천식 & 면역학, 알레르기성 비염은 인구의 10~30%에 영향을 미치며, 약물이상반응은 전 세계 인구의 최대 10%, 입원 환자의 거의 20%에 영향을 미칠 수 있습니다. 2018년 실시된 국립보건통계센터 조사 자료에 따르면 지난 12개월 동안 보고된 호흡기 알레르기 건수는 710만 건, 식품 알레르기 건수는 480만 건, 피부 알레르기 건수 920만 건이었습니다.

면역요법은 집 먼지 진드기, 벌독, 꽃가루 등의 물질에 대한 알레르기 반응을 예방하는 치료법입니다. 면역요법은 환자가 알레르기 반응을 보이는 알레르기 항원이나 물질의 용량을 점진적으로 증가시키는 것입니다. 알레르겐의 복용량이 증가하면 아마도 "차단" 항체의 생성을 유도하여 면역 체계가 물질에 덜 민감하게 됩니다. 이는 나중에 해당 물질을 접할 때 알레르기 증상을 낮추는 역할을 합니다. 면역요법은 또한 천식과 비염의 특징인 염증을 감소시킵니다. 알레르기 질환은 대부분 면역요법으로 치료됩니다. 따라서 알레르기 질환의 확산이 증가하면서 시장이 성장하게 됩니다.

치료 기반 통찰력

치료를 기반으로 하는 전 세계 알레르기 면역치료 시장은 피하 면역치료(SCIT)와 설하 면역치료(SLIT)로 구분됩니다. 2019년 피하 면역요법(SCIT) 부문은 치료 기준으로 시장에서 가장 큰 점유율을 차지했습니다. 그러나 설하 면역치료(SLIT) 부문은 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.

            ;                           ;                           ;                           ;                 

치료별 글로벌 알레르기 면역치료제 시장– 2019 & 2027

알레르기 유형 기반 통찰력

알레르기 유형을 기준으로 전 세계 알레르기 면역치료제 시장은 알레르기성 비염, 천식, 음식 알레르기, 독 알레르기, 다른 사람. 알레르기 비염 부문은 2019년 알레르기 유형별로 알레르기 면역치료제 시장에서 가장 높은 점유율을 차지했습니다. 더욱이, 동일한 부문은 2020년부터 2027년까지 예측 기간 동안 상당한 비율로 성장할 것으로 예상됩니다.

유통 채널 기반 통찰력

글로벌 알레르기 면역치료제 시장은 유통채널을 기준으로 병원약국, 소매약국, 온라인약국으로 구분됩니다. 2019년에는 병원 약국 설정 부문이 유통 채널 기준으로 시장에서 가장 큰 점유율을 차지했습니다. 더욱이 동일한 약국 부문은 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.

제품 출시 및 확장 전략은 기업이 전 세계적으로 입지를 확장하고 증가하는 수요를 충족합니다. 이러한 전략은 제품 포트폴리오를 확장하기 위해 시장 참여자들이 일반적으로 채택합니다.

알레르기 면역요법 시장에서 활동하는 시장 참여자들은 변화하는 고객에 부응하기 위해 제품 혁신 전략을 채택했습니다. 이는 또한 플레이어가 전 세계적으로 브랜드 이름을 유지할 수 있도록 허용합니다.

치료별

  • 피하 면역 요법(SCIT)
  • 설하 면역치료(SLIT)

알레르기 유형별

  • 알레르기성 비염
  • 천식
  • 음식 알레르기
  • 독 알레르기
  • 기타

유통 채널별

  • 병원 약국

    li>
  • 소매 약국
  • 온라인 약국

지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 프랑스
    • 독일
    • < li>이탈리아
    • 영국
    • 스페인
  • 아시아 태평양(APAC)
    • 중국
    • 인도
    • 대한민국
    • 일본
    • 호주
  • 중동 및amp; 아프리카(MEA)
    • 남아프리카
    • 사우디아라비아
    • UAE
  • 남아메리카(SAM)< ul>
  • 브라질
  • 아르헨티나

회사 프로필

  • ALK-Abelló A/S
  • AIMMUNE THERAPEUTICS, INC.
  • LETIPharma
  • Stallergenes Greer
  • HAL Allergy BV
  • Johnson 및 Johnson Services, Inc.
  • Anergis
  • DBV Technologies
  • Dermapharm Holding
  • Allergy Therapeutics
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the allergy immunotherapies market?

The allergy immunotherapy market majorly consists of the players such as ALK-Abelló A/S, AIMMUNE THERAPEUTICS, INC., LETIPharma, Stallergenes Greer, HAL Allergy B.V., Anergis, DBV Technologies, Dermapharm Holding, Allergy Therapeutics, ASIT biotech are among others.

What are the driving factors for the allergy immunotherapies market across the globe?

The factors that are driving the growth of the market are increasing prevalence of allergic disorders and rising preference for immunotherapies due to efficacy and cost-effectiveness are expected to boost the growth of the global allergy immunotherapy market.

What is allergy Immunotherapy?

Allergy Immunotherapy is an allergy treatment process that involves administering small quantities of allergens into your body and then building up doses slowly over some time until the patient develops immunity. Two types of immunotherapy therapies are available in the market, such as subcutaneous immunotherapy (SCIT), also called allergy shots, and sublingual immunotherapy (SLIT). Individuals with symptoms of allergy and do not respond to conventional medical treatments are the potential targets for allergen immunotherapy.

The List of Companies - Allergy Immunotherapies Market

  1. ALK-Abelló A/S
  2. AIMMUNE THERAPEUTICS, INC.
  3. LETIPharma
  4. Stallergenes Greer
  5. HAL Allergy B.V.
  6. Johnson and Johnson Services, Inc.
  7. Anergis
  8. DBV Technologies
  9. Dermapharm Holding
  10. Allergy Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports